Texas Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Technology Digest.

Press releases published on October 6, 2026

an hour ago

Regeneron Showcases Advances in Care Across Several Cancers and Cancer-associated Complications at ESMO 2026

Indeterminate GlobeNewswire

an hour ago

Freehand CEO Nitin Jayakrishnan Addresses Supply Chain Disruption and Resilience at LogiPharma USA 2026

Indeterminate GlobeNewswire

an hour ago

InNova Global Fund Opens Reg D 506(c) Offering to Fund Microlending in Kenya

Indeterminate GlobeNewswire

an hour ago

SignWell Partners With TD SYNNEX to Scale Enterprise-Grade eSignature Platform Across Partner Ecosystem

Indeterminate GlobeNewswire

an hour ago

OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain

Indeterminate GlobeNewswire

an hour ago

ServiceTitan Announcing New and Expanded Capabilities at Pantheon 2026

Indeterminate GlobeNewswire

an hour ago

MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics

Indeterminate GlobeNewswire

2 hours ago

Descartes Unveils Next Step in Supply Chain AI with Agent Control Plane

Indeterminate GlobeNewswire

2 hours ago

Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update

Indeterminate GlobeNewswire

2 hours ago

Virtune AB (Publ) Launches Virtune Zcash ETP on Nasdaq Stockholm

Indeterminate GlobeNewswire

2 hours ago

Virtune AB (Publ) lanseeraa Virtune Zcash ETP:n Nasdaq Stockholmissa

Indeterminate GlobeNewswire

2 hours ago

Virtune AB (Publ) lanserar Virtune Zcash ETP på Nasdaq Stockholm

Indeterminate GlobeNewswire

2 hours ago

Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy

Indeterminate GlobeNewswire

2 hours ago

First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)

Indeterminate GlobeNewswire

2 hours ago

Minerva Humanoids Emerges From Stealth With $10M Pre-Seed Round Led by General Catalyst to Build Humanoid Robots for the World's Most Dangerous Jobs

Indeterminate GlobeNewswire

2 hours ago

Zscaler Hosts 2026 Investor Day, Reaffirms First Quarter and Fiscal 2027 Guidance

Indeterminate GlobeNewswire

2 hours ago

Applied Digital Secures Up to 1 GW of Potential Power Capacity in Finland, Marking First International Development in the Nordics

Indeterminate GlobeNewswire

2 hours ago

MediciNova to Participate in the Maxim Growth Summit

Indeterminate GlobeNewswire

3 hours ago

PathMaker Neurosystems Announces Publication of First-Ever Study Showing Non-Invasive Clearance of Toxic TDP-43 Protein Aggregates in Preclinical ALS Study

Indeterminate GlobeNewswire

3 hours ago

Roadzen to Present at Maxim Growth Summit and ThinkEquity Conference

Indeterminate GlobeNewswire